Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration.

Cook DR, Solski PA, Bultman SJ, Kauselmann G, Schoor M, Kuehn R, Friedman LS, Cowley DO, Van Dyke T, Yeh JJ, Johnson L, Der CJ.

Genes Cancer. 2011 Oct;2(10):932-42. doi: 10.1177/1947601912437035.

2.

Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.

Loomis RJ, Holmes DA, Elms A, Solski PA, Der CJ, Su L.

Traffic. 2006 Dec;7(12):1643-53.

3.

Requirement for C-terminal sequences in regulation of Ect2 guanine nucleotide exchange specificity and transformation.

Solski PA, Wilder RS, Rossman KL, Sondek J, Cox AD, Campbell SL, Der CJ.

J Biol Chem. 2004 Jun 11;279(24):25226-33. Epub 2004 Apr 8.

4.
5.

RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Solski PA, Helms W, Keely PJ, Su L, Der CJ.

Cell Growth Differ. 2002 Aug;13(8):363-73.

6.

Analyses of transforming activity of Rho family activators.

Solski PA, Abe K, Der CJ.

Methods Enzymol. 2000;325:425-41. No abstract available.

PMID:
11036624
7.

Modulation of HIV-1 replication by a novel RhoA effector activity.

Wang L, Zhang H, Solski PA, Hart MJ, Der CJ, Su L.

J Immunol. 2000 May 15;164(10):5369-74.

8.

Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.

Murphy GA, Solski PA, Jillian SA, Pérez de la Ossa P, D'Eustachio P, Der CJ, Rush MG.

Oncogene. 1999 Jul 1;18(26):3831-45.

9.

A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformation.

Booden MA, Baker TL, Solski PA, Der CJ, Punke SG, Buss JE.

J Biol Chem. 1999 Jan 15;274(3):1423-31.

10.

Novel determinants of H-Ras plasma membrane localization and transformation.

Willumsen BM, Cox AD, Solski PA, Der CJ, Buss JE.

Oncogene. 1996 Nov 7;13(9):1901-9.

PMID:
8934536
11.

Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ.

Mol Cell Biol. 1996 Jul;16(7):3923-33.

12.

Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation.

Galang CK, García-Ramírez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG, Hauser CA.

J Biol Chem. 1996 Apr 5;271(14):7992-8.

14.

Guanine nucleotide exchange factors: activators of Ras superfamily proteins.

Overbeck AF, Brtva TR, Cox AD, Graham SM, Huff SY, Khosravi-Far R, Quilliam LA, Solski PA, Der CJ.

Mol Reprod Dev. 1995 Dec;42(4):468-76. Review.

PMID:
8607978
15.

Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.

Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ.

Mol Cell Biol. 1995 Nov;15(11):6443-53.

16.

Critical role of Rho in cell transformation by oncogenic Ras.

Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ.

Oncogene. 1995 Jun 15;10(12):2289-96.

PMID:
7784077
17.

Analysis of Ras protein expression in mammalian cells.

Cox AD, Solski PA, Jordan JD, Der CJ.

Methods Enzymol. 1995;255:195-220. No abstract available.

PMID:
8524103
18.

Targeting proteins to membranes using signal sequences for lipid modification.

Solski PA, Quilliam LA, Coats SG, Der CJ, Buss JE.

Methods Enzymol. 1995;250:435-54.

PMID:
7651170
19.

Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.

Khosravi-Far R, Chrzanowska-Wodnicka M, Solski PA, Eva A, Burridge K, Der CJ.

Mol Cell Biol. 1994 Oct;14(10):6848-57.

20.

The carboxyl-terminal CXXX sequence of Gi alpha, but not Rab5 or Rab11, supports Ras processing and transforming activity.

Cox AD, Graham SM, Solski PA, Buss JE, Der CJ.

J Biol Chem. 1993 Jun 5;268(16):11548-52.

21.

The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.

Buss JE, Quilliam LA, Kato K, Casey PJ, Solski PA, Wong G, Clark R, McCormick F, Bokoch GM, Der CJ.

Mol Cell Biol. 1991 Mar;11(3):1523-30.

23.

Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.

Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):3042-6.

24.

p21ras is modified by a farnesyl isoprenoid.

Casey PJ, Solski PA, Der CJ, Buss JE.

Proc Natl Acad Sci U S A. 1989 Nov;86(21):8323-7.

25.

Activation of cellular p21ras by myristoylation.

Buss JE, Solski PA, Schaeffer JP, MacDonald MJ, Der CJ.

Biochem Soc Trans. 1989 Oct;17(5):867-9.

PMID:
2695362
26.

Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal.

Buss JE, Solski PA, Schaeffer JP, MacDonald MJ, Der CJ.

Science. 1989 Mar 24;243(4898):1600-3.

PMID:
2648572
27.
28.

Receptor-mediated inositol phosphate formation in relation to calcium mobilization: a comparison of two cell lines.

Ambler SK, Thompson B, Solski PA, Brown JH, Taylor P.

Mol Pharmacol. 1987 Sep;32(3):376-83.

PMID:
2823090
30.

Supplemental Content

Loading ...
Support Center